Screener
Compass Therapeutics, Inc. CMPX Q2 2026 earnings
Reported August 6, 2026 · Before market open
EPS-$0.13Miss by $0.02
Revenue estimate-$600.0K
EPS estimate-$0.11
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$229.3K
EPS estimate-$0.12
Versus estimates
Diluted EPS
FAQ
- When did Compass Therapeutics, Inc. report Q2 2026 earnings?
- Compass Therapeutics, Inc. (CMPX) reported Q2 2026 earnings on August 6, 2026 before market open.
- What were Compass Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Compass Therapeutics, Inc. reported eps of $-0.13 for Q2 2026.
- Did Compass Therapeutics, Inc. beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.11 by $0.02.
- How did Compass Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 7.1% from $-0.14.
- Where can I find Compass Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001171843-26-005292) and the 10-Q periodic report (0001171843-26-005295) directly on SEC EDGAR. The filing index links above go to sec.gov.
